These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23377219)

  • 1. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
    Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
    Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of KIT receptor in feline cutaneous mast cell tumors.
    Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
    Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
    Sabattini S; Bettini G
    Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours.
    Sabattini S; Barzon G; Giantin M; Lopparelli RM; Dacasto M; Prata D; Bettini G
    Vet Comp Oncol; 2017 Sep; 15(3):1051-1061. PubMed ID: 27278268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
    Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
    J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
    Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
    Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate.
    Isotani M; Tamura K; Yagihara H; Hikosaka M; Ono K; Washizu T; Bonkobara M
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):168-72. PubMed ID: 16908071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
    Isotani M; Yamada O; Lachowicz JL; Tamura K; Yagihara H; Fujino Y; Ono K; Washizu T; Bonkobara M
    Br J Haematol; 2010 Jan; 148(1):144-53. PubMed ID: 19804453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
    Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
    Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of c-KIT protein in feline soft tissue fibrosarcomas.
    Smith AJ; Njaa BL; Lamm CG
    Vet Pathol; 2009 Sep; 46(5):934-9. PubMed ID: 19429996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats.
    Dank G; Chien MB; London CA
    Am J Vet Res; 2002 Aug; 63(8):1129-33. PubMed ID: 12171166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive detection of the c-KIT c.1430G>T mutation by mutant-specific polymerase chain reaction in feline mast cell tumours.
    Takanosu M; Sato M; Kagawa Y
    Vet Comp Oncol; 2014 Jun; 12(2):138-42. PubMed ID: 22891713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
    Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Phosphorylated KIT in Canine Mast Cell Tumor.
    Halsey CHC; Thamm DH; Weishaar KM; Burton JH; Charles JB; Gustafson DL; Avery AC; Ehrhart EJ
    Vet Pathol; 2017 May; 54(3):387-394. PubMed ID: 28129097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
    Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
    J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic characteristics and KIT staining patterns of equine cutaneous mast cell tumors.
    Clarke L; Simon A; Ehrhart EJ; Mulick J; Charles B; Powers B; Duncan C
    Vet Pathol; 2014 May; 51(3):560-2. PubMed ID: 23794148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline intestinal mast cell tumours: clinicopathological characterisation and KIT mutation analysis.
    Sabattini S; Giantin M; Barbanera A; Zorro Shahidian L; Dacasto M; Zancanella V; Prata D; Trivigno E; Bettini G
    J Feline Med Surg; 2016 Apr; 18(4):280-9. PubMed ID: 25916685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.